{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:28:51Z","timestamp":1790278131202,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01607-z","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T17:49:44Z","timestamp":1731520184000},"page":"1427-1443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phytochemicals in Parkinson\u2019s Disease: a Pathway to Neuroprotection and Personalized Medicine"],"prefix":"10.1007","volume":"83","author":[{"given":"Soumik","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Devi","family":"Rajeswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnanasambandan","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"1607_CR1","unstructured":"Foundation Ps. Understanding Parkinson\u2019s Statistics: Parkinson\u2019s Foundation; 2023 [Available from: https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics]."},{"issue":"1","key":"1607_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., & Ray Chaudhuri, K., et al. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews in Disease Primers, 7(1), 47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3.","journal-title":"Nature Reviews in Disease Primers"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"356.","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"M Gomez-Benito","year":"2020","unstructured":"Gomez-Benito, M., Granado, N., Garcia-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020). Modeling Parkinson\u2019s Disease With the Alpha-Synuclein Protein. Frontiers in Pharmacology, 11, 356. https:\/\/doi.org\/10.3389\/fphar.2020.00356.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR4","doi-asserted-by":"publisher","unstructured":"Teleanu D. M., Niculescu A. G., Lungu, I. I., Radu C. I., Vladacenco O., Roza E., et al. (2022). An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. International Journal of Molecular Science, 23(11). https:\/\/doi.org\/10.3390\/ijms23115938.","DOI":"10.3390\/ijms23115938"},{"issue":"10","key":"1607_CR5","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/mds.27776","volume":"34","author":"M Vila","year":"2019","unstructured":"Vila, M. (2019). Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease. Movement Disorder, 34(10), 1440\u20131451. https:\/\/doi.org\/10.1002\/mds.27776.","journal-title":"Movement Disorder"},{"issue":"3","key":"1607_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awac445","volume":"146","author":"M Gonzalez-Sepulveda","year":"2023","unstructured":"Gonzalez-Sepulveda, M., Compte, J., Cuadros, T., Nicolau, A., Guillard-Sirieix, C., & Penuelas, N., et al. (2023). In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease. Brain, 146(3), 1040\u20131052. https:\/\/doi.org\/10.1093\/brain\/awac445.","journal-title":"Brain"},{"key":"1607_CR7","doi-asserted-by":"publisher","unstructured":"Stoker T. B., & Barker R. A. (2020). Recent developments in the treatment of Parkinson\u2019s Disease. F1000Res. 9. https:\/\/doi.org\/10.12688\/f1000research.25634.1.","DOI":"10.12688\/f1000research.25634.1"},{"key":"1607_CR8","doi-asserted-by":"publisher","unstructured":"Johnson S. L., Park H. Y., DaSilva N. A., Vattem D. A., Ma H., & Seeram N. P. (2018). Levodopa-Reduced Mucuna pruriens Seed Extract Shows Neuroprotective Effects against Parkinson\u2019s Disease in Murine Microglia and Human Neuroblastoma Cells, Caenorhabditis elegans, and Drosophila melanogaster. Nutrients. 10(9). https:\/\/doi.org\/10.3390\/nu10091139.","DOI":"10.3390\/nu10091139"},{"issue":"14","key":"1607_CR9","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1021\/acschemneuro.1c00153","volume":"12","author":"L Subedi","year":"2021","unstructured":"Subedi, L., & Gaire, B. P. (2021). Neuroprotective Effects of Curcumin in Cerebral Ischemia: Cellular and Molecular Mechanisms. ACS Chemical Neuroscience, 12(14), 2562\u20132572. https:\/\/doi.org\/10.1021\/acschemneuro.1c00153.","journal-title":"ACS Chemical Neuroscience"},{"issue":"12","key":"1607_CR10","first-page":"1089","volume":"22","author":"SF Yang","year":"2001","unstructured":"Yang, S. F., Wu, Q., Sun, A. S., Huang, X. N., & Shi, J. S. (2001). Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacology Sinica, 22(12), 1089\u20131093.","journal-title":"Acta Pharmacology Sinica"},{"issue":"10","key":"1607_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2165\/00002512-200320100-00001","volume":"20","author":"T Pan","year":"2003","unstructured":"Pan, T., Jankovic, J., & Le, W. (2003). Potential therapeutic properties of green tea polyphenols in Parkinson\u2019s disease. Drugs Aging, 20(10), 711\u2013721. https:\/\/doi.org\/10.2165\/00002512-200320100-00001.","journal-title":"Drugs Aging"},{"issue":"4","key":"1607_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","volume":"36","author":"IH Cho","year":"2012","unstructured":"Cho, I. H. (2012). Effects of Panax ginseng in Neurodegenerative Diseases. Journal of Ginseng Research, 36(4), 342\u2013353. https:\/\/doi.org\/10.5142\/jgr.2012.36.4.342.","journal-title":"Journal of Ginseng Research"},{"issue":"1","key":"1607_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemical Cell Biology, 39(1), 44\u201384. https:\/\/doi.org\/10.1016\/j.biocel.2006.07.001.","journal-title":"International Journal of Biochemical Cell Biology"},{"key":"1607_CR14","doi-asserted-by":"publisher","unstructured":"Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 24(8). https:\/\/doi.org\/10.3390\/molecules24081583.","DOI":"10.3390\/molecules24081583"},{"issue":"8649","key":"1607_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/s0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira, A. H., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989). Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet, 1(8649), 1269. https:\/\/doi.org\/10.1016\/s0140-6736(89)92366-0.","journal-title":"Lancet"},{"issue":"Suppl 4","key":"1607_CR16","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S1353-8020(09)70834-X","volume":"15","author":"AH Schapira","year":"2009","unstructured":"Schapira, A. H. (2009). Neuroprotection in Parkinson\u2019s disease. Parkinsonism Related Disorder, 15(Suppl 4), S41\u2013S43. https:\/\/doi.org\/10.1016\/S1353-8020(09)70834-X.","journal-title":"Parkinsonism Related Disorder"},{"issue":"8","key":"1607_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.molcel.2022.03.025","volume":"82","author":"RL Wiseman","year":"2022","unstructured":"Wiseman, R. L., Mesgarzadeh, J. S., & Hendershot, L. M. (2022). Reshaping endoplasmic reticulum quality control through the unfolded protein response. Molecular Cell, 82(8), 1477\u20131491. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.025.","journal-title":"Molecular Cell"},{"issue":"3","key":"1607_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans, J. J., van Haastert, E. S., Eikelenboom, P., de Vos, R. A., Rozemuller, J. M., & Scheper, W. (2007). Activation of the unfolded protein response in Parkinson\u2019s disease. Biochemistry Biophysics Research Communication, 354(3), 707\u2013711. https:\/\/doi.org\/10.1016\/j.bbrc.2007.01.043.","journal-title":"Biochemistry Biophysics Research Communication"},{"key":"1607_CR19","first-page":"1","volume-title":"Pathology, Prevention and Therapeutics of Neurodegenerative Disease","author":"PP Arti Parihar","year":"2018","unstructured":"Arti Parihar, P. P., Solanki, I., & Parihar, M. S. (2018). Alpha Synuclein and Parkinson\u2019s Disease. In N. J. Sarika Singh editor, Pathology, Prevention and Therapeutics of Neurodegenerative Disease (pp. 1\u201314). Singapore: Springer."},{"issue":"7","key":"1607_CR20","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","volume":"59","author":"T Behl","year":"2022","unstructured":"Behl, T., Kumar, S., Althafar, Z. M., Sehgal, A., Singh, S., & Sharma, N., et al. (2022). Exploring the Role of Ubiquitin-Proteasome System in Parkinson\u2019s Disease. Mol Neurobiol, 59(7), 4257\u20134273. https:\/\/doi.org\/10.1007\/s12035-022-02851-1.","journal-title":"Mol Neurobiol"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuro.2014.07.006","volume":"44","author":"S Sarkar","year":"2014","unstructured":"Sarkar, S., Chigurupati, S., Raymick, J., Mann, D., Bowyer, J. F., & Schmitt, T., et al. (2014). Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson\u2019s disease mouse model. Neurotoxicology, 44, 250\u2013262. https:\/\/doi.org\/10.1016\/j.neuro.2014.07.006.","journal-title":"Neurotoxicology"},{"issue":"11","key":"1607_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022). Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology, 22(11), 657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6.","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"1607_CR23","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","volume":"20","author":"SX Ma","year":"2021","unstructured":"Ma, S. X., Seo, B. A., Kim, D., Xiong, Y., Kwon, S. H., & Brahmachari, S., et al. (2021). Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in alpha-Synuclein-Based Mouse Models of Parkinson\u2019s Disease. Journal of Proteome Research, 20(7), 3428\u20133443. https:\/\/doi.org\/10.1021\/acs.jproteome.0c01002.","journal-title":"Journal of Proteome Research"},{"issue":"6","key":"1607_CR24","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","volume":"104","author":"AD Reynolds","year":"2008","unstructured":"Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., & Ciborowski, P., et al. (2008). Nitrated alpha-synuclein-activated microglial profiling for Parkinson\u2019s disease. Journal of Neurochemistry, 104(6), 1504\u20131525. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05087.x.","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"1607_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., & Block, M. L., et al. (2005). Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J, 19(6), 533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com.","journal-title":"FASEB J"},{"issue":"12","key":"1607_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008). Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. Journal of Neuropathology & Experimental Neurology, 67(12), 1149\u20131158. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e5e99.","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"1607_CR27","doi-asserted-by":"publisher","first-page":"19.","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Liu, Y., & Zhou, J. (2015). Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Translational Neurodegeneration, 4, 19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0.","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"1607_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy, O. A., Malagelada, C., & Greene, L. A. (2009). Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps. Apoptosis, 14(4), 478\u2013500. https:\/\/doi.org\/10.1007\/s10495-008-0309-3.","journal-title":"Apoptosis"},{"key":"1607_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dionisio","year":"2021","unstructured":"Dionisio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021). Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Research & Review, 67, 101263. https:\/\/doi.org\/10.1016\/j.arr.2021.101263.","journal-title":"Ageing Research & Review"},{"key":"1607_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147639","volume":"1771","author":"A Memou","year":"2021","unstructured":"Memou, A., Dimitrakopoulos, L., Kedariti, M., Kentros, M., Lamprou, A., & Petropoulou-Vathi, L., et al. (2021). Defining (and blocking) neuronal death in Parkinson\u2019s disease: Does it matter what we call it? Brain Research, 1771, 147639. https:\/\/doi.org\/10.1016\/j.brainres.2021.147639.","journal-title":"Brain Research"},{"issue":"2","key":"1607_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013). GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & Therapeutics, 138(2), 155\u2013175. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.004.","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"1607_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.27943","volume":"35","author":"AK Mahato","year":"2020","unstructured":"Mahato, A. K., Kopra, J., Renko, J. M., Visnapuu, T., Korhonen, I., & Pulkkinen, N., et al. (2020). Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo. Movement Disorders, 35(2), 245\u2013255. https:\/\/doi.org\/10.1002\/mds.27943.","journal-title":"Movement Disorders"},{"key":"1607_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2018.05.014","volume":"147","author":"R Grondin","year":"2019","unstructured":"Grondin, R., Littrell, O. M., Zhang, Z., Ai, Y., Huettl, P., & Pomerleau, F., et al. (2019). GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology, 147, 28\u201336. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.05.014.","journal-title":"Neuropharmacology"},{"key":"1607_CR34","doi-asserted-by":"publisher","unstructured":"Nebrisi E. E. (2021). Neuroprotective Activities of Curcumin in Parkinson\u2019s Disease: A Review of the Literature. International Journal of Molecular Science 22(20). https:\/\/doi.org\/10.3390\/ijms222011248.","DOI":"10.3390\/ijms222011248"},{"issue":"1","key":"1607_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12640-021-00450-x","volume":"40","author":"MG Dos Santos","year":"2022","unstructured":"Dos Santos, M. G., Schimith, L. E., Andre-Miral, C., Muccillo-Baisch, A. L., Arbo, B. D., & Hort, M. A. (2022). Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson\u2019s Disease: a Systematic Review. Neurotox Research, 40(1), 319\u2013345. https:\/\/doi.org\/10.1007\/s12640-021-00450-x.","journal-title":"Neurotox Research"},{"key":"1607_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105799","volume":"115","author":"CK Bhusal","year":"2023","unstructured":"Bhusal, C. K., Uti, D. E., Mukherjee, D., Alqahtani, T., Alqahtani, S., & Bhattacharya, A., et al. (2023). Unveiling Nature\u2019s potential: Promising natural compounds in Parkinson\u2019s disease management. Parkinsonism Related Disorders, 115, 105799. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105799.","journal-title":"Parkinsonism Related Disorders"},{"key":"1607_CR37","doi-asserted-by":"publisher","unstructured":"Lo Cascio, F., Marzullo, P., Kayed, R., & Palumbo Piccionello, A. (2021). Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases. Biomedicines. 9(2). https:\/\/doi.org\/10.3390\/biomedicines9020173.","DOI":"10.3390\/biomedicines9020173"},{"key":"1607_CR38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3389\/fphar.2018.01555","volume":"9","author":"H Javed","year":"2018","unstructured":"Javed, H., Nagoor Meeran, M. F., Azimullah, S., Adem, A., Sadek, B., & Ojha, S. K. (2018). Plant Extracts and Phytochemicals Targeting alpha-Synuclein Aggregation in Parkinson\u2019s Disease Models. Frontiers in Pharmacology, 9, 1555. https:\/\/doi.org\/10.3389\/fphar.2018.01555.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"1607_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/iub.2654","volume":"75","author":"FA Zucca","year":"2023","unstructured":"Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., & Monzani, E., et al. (2023). Neuromelanins in brain aging and Parkinson\u2019s disease: synthesis, structure, neuroinflammatory, and neurodegenerative role. IUBMB Life, 75(1), 55\u201365. https:\/\/doi.org\/10.1002\/iub.2654.","journal-title":"IUBMB Life"},{"key":"1607_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.fitote.2012.12.009","volume":"84","author":"XZ Li","year":"2013","unstructured":"Li, X. Z., Zhang, S. N., Liu, S. M., & Lu, F. (2013). Recent advances in herbal medicines treating Parkinson\u2019s disease. Fitoterapia, 84, 273\u2013285. https:\/\/doi.org\/10.1016\/j.fitote.2012.12.009.","journal-title":"Fitoterapia"},{"key":"1607_CR41","doi-asserted-by":"publisher","unstructured":"So, Y. J., Lee, J. U., Yang, G. S., Yang, G., Kim, S. W., & Lee, J. H. et al. (2024). The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson\u2019s Disease: A Promising Therapeutic Approach. International Journal of Molecular Science, 25(2). https:\/\/doi.org\/10.3390\/ijms25021071.","DOI":"10.3390\/ijms25021071"},{"issue":"9","key":"1607_CR42","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2174\/1570159X19666210412095251","volume":"19","author":"D Lobine","year":"2021","unstructured":"Lobine, D., Sadeer, N., Jugreet, S., Suroowan, S., Keenoo, B. S., & Imran, M., et al. (2021). Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-beta-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells. Current Neuropharmacology, 19(9), 1416\u20131441. https:\/\/doi.org\/10.2174\/1570159X19666210412095251.","journal-title":"Current Neuropharmacology"},{"issue":"12","key":"1607_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-7847.99898","volume":"6","author":"GP Kumar","year":"2012","unstructured":"Kumar, G. P., & Khanum, F. (2012). Neuroprotective potential of phytochemicals. Pharmacognosy Review, 6(12), 81\u201390. https:\/\/doi.org\/10.4103\/0973-7847.99898.","journal-title":"Pharmacognosy Review"},{"key":"1607_CR44","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.2147\/JIR.S316314","volume":"14","author":"L Li","year":"2021","unstructured":"Li, L., Fan, S., Zhang, W., Li, D., Yang, Z., & Zhuang, P., et al. (2021). Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice. Journal of Inflammation Research, 14, 3261\u20133276. https:\/\/doi.org\/10.2147\/JIR.S316314.","journal-title":"Journal of Inflammation Research"},{"key":"1607_CR45","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fphar.2018.01444","volume":"9","author":"JH Choi","year":"2018","unstructured":"Choi, J. H., Jang, M., Lee, J. I., Chung, W. S., & Cho, I. H. (2018). Neuroprotective Effects of a Traditional Multi-Herbal Medicine Kyung-Ok-Ko in an Animal Model of Parkinson\u2019s Disease: Inhibition of MAPKs and NF-kappaB Pathways and Activation of Keap1-Nrf2 Pathway. Frontiers in Pharmacology, 9, 1444. https:\/\/doi.org\/10.3389\/fphar.2018.01444.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"1607_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jep.2013.01.005","volume":"146","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., Sun, H. M., He, X., Wang, Y. Y., Gao, Y. S., & Wu, H. X., et al. (2013). Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson\u2019s disease. Journal of Ethnopharmacology, 146(1), 363\u2013371. https:\/\/doi.org\/10.1016\/j.jep.2013.01.005.","journal-title":"Journal of Ethnopharmacology"},{"issue":"7","key":"1607_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.49","volume":"48","author":"M Ye","year":"2016","unstructured":"Ye, M., Chung, H. S., Lee, C., Hyun Song, J., Shim, I., & Kim, Y. S., et al. (2016). Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson\u2019s disease alpha-synuclein transgenic mice. Experimental Molecular Medicine, 48(7), e244. https:\/\/doi.org\/10.1038\/emm.2016.49.","journal-title":"Experimental Molecular Medicine"},{"key":"1607_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jep.2016.08.020","volume":"197","author":"N Pathak-Gandhi","year":"2017","unstructured":"Pathak-Gandhi, N., & Vaidya, A. D. (2017). Management of Parkinson\u2019s disease in Ayurveda: Medicinal plants and adjuvant measures. Journal of Ethnopharmacology, 197, 46\u201351. https:\/\/doi.org\/10.1016\/j.jep.2016.08.020.","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"1607_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.34172\/apb.2021.026","volume":"11","author":"MR Khazdair","year":"2021","unstructured":"Khazdair, M. R., Kianmehr, M., & Anaeigoudari, A. (2021). Effects of Medicinal Plants and Flavonoids on Parkinson\u2019s Disease: A Review on Basic and Clinical Evidences. Advanced Pharma Bulletein, 11(2), 224\u2013232. https:\/\/doi.org\/10.34172\/apb.2021.026.","journal-title":"Advanced Pharma Bulletein"},{"key":"1607_CR50","doi-asserted-by":"publisher","unstructured":"Arash Abdolmaleki, M. A., Saeed, M. M., Asadi, A., & Kajkolah M. (2020). Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview. Journal of Pharmaceutical Care. 8. https:\/\/doi.org\/10.18502\/jpc.v8i2.3832.","DOI":"10.18502\/jpc.v8i2.3832"},{"issue":"4","key":"1607_CR51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s2225-4110(16)30119-5","volume":"2","author":"LR Lampariello","year":"2012","unstructured":"Lampariello, L. R., Cortelazzo, A., Guerranti, R., Sticozzi, C., & Valacchi, G. (2012). The Magic Velvet Bean of Mucuna pruriens. Journal of Traditional Complementary Medicine, 2(4), 331\u2013339. https:\/\/doi.org\/10.1016\/s2225-4110(16)30119-5.","journal-title":"Journal of Traditional Complementary Medicine"},{"key":"1607_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neuint.2016.09.014","volume":"100","author":"W Liu","year":"2016","unstructured":"Liu, W., Ma, H., DaSilva, N. A., Rose, K. N., Johnson, S. L., & Zhang, L., et al. (2016). Development of a neuroprotective potential algorithm for medicinal plants. Neurochemistry International, 100, 164\u2013177. https:\/\/doi.org\/10.1016\/j.neuint.2016.09.014.","journal-title":"Neurochemistry International"},{"issue":"11","key":"1607_CR53","first-page":"273","volume":"7","author":"Krishnamoorthy GSaG.","year":"2018","unstructured":"Krishnamoorthy GSaG. (2018). Nutraceutical and phytochemical investigation of Mucuna pruriens seed. The Pharma Innovation Journal, 7(11), 273\u2013278.","journal-title":"The Pharma Innovation Journal"},{"key":"1607_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2013.12.001","volume":"65","author":"SK Yadav","year":"2014","unstructured":"Yadav, S. K., Prakash, J., Chouhan, S., Westfall, S., Verma, M., & Singh, T. D., et al. (2014). Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochemistry International, 65, 1\u201313. https:\/\/doi.org\/10.1016\/j.neuint.2013.12.001.","journal-title":"Neurochemistry International"},{"key":"1607_CR55","doi-asserted-by":"publisher","unstructured":"Duarte G. M., de Araujo F. E. A., da Rocha J. M. C., Idalina Neta F., do Rego A. C. M., & Araujo Filho I., et al. (2023). Neuroprotective Potential of Seed Extracts: Review of In Vitro and In Vivo Studies. Nutrients. 15(11). https:\/\/doi.org\/10.3390\/nu15112502.","DOI":"10.3390\/nu15112502"},{"key":"1607_CR56","doi-asserted-by":"publisher","first-page":"421.","DOI":"10.3389\/fnagi.2017.00421","volume":"9","author":"SN Rai","year":"2017","unstructured":"Rai, S. N., Birla, H., Singh, S. S., Zahra, W., Patil, R. R., & Jadhav, J. P., et al. (2017). Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson\u2019s Disease through NF-kappaB\/pAKT Signaling Pathways. Frontiers in Aging Neuroscience, 9, 421. https:\/\/doi.org\/10.3389\/fnagi.2017.00421.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"1607_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11101-017-9528-y","volume":"17","author":"NE Gray","year":"2018","unstructured":"Gray, N. E., Alcazar Magana, A., Lak, P., Wright, K. M., Quinn, J., & Stevens, J. F., et al. (2018). Centella asiatica - Phytochemistry and mechanisms of neuroprotection and cognitive enhancement. Phytochemical Review, 17(1), 161\u2013194. https:\/\/doi.org\/10.1007\/s11101-017-9528-y.","journal-title":"Phytochemical Review"},{"issue":"10","key":"1607_CR58","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.22038\/ijbms.2019.29012.7002","volume":"22","author":"DCR Sari","year":"2019","unstructured":"Sari, D. C. R., Arfian, N., Tranggono, U., Setyaningsih, W. A. W., Romi, M. M., & Emoto, N. (2019). Centella asiatica (Gotu kola) ethanol extract up-regulates hippocampal brain-derived neurotrophic factor (BDNF), tyrosine kinase B (TrkB) and extracellular signal-regulated protein kinase 1\/2 (ERK1\/2) signaling in chronic electrical stress model in rats. Iran Journal of Basic Medical Science, 22(10), 1218\u20131224. https:\/\/doi.org\/10.22038\/ijbms.2019.29012.7002.","journal-title":"Iran Journal of Basic Medical Science"},{"key":"1607_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tifs.2018.07.024","volume":"79","author":"B Fedrizzi","year":"2018","unstructured":"Rasangani Sabaragamuwa COP, Fedrizzi, B. (2018). Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing. Trends in Food Science & Technology, 79, 88\u201397. https:\/\/doi.org\/10.1016\/j.tifs.2018.07.024.","journal-title":"Trends in Food Science & Technology"},{"issue":"1","key":"1607_CR60","first-page":"4","volume":"23","author":"Y Lokanathan","year":"2016","unstructured":"Lokanathan, Y., Omar, N., Ahmad Puzi, N. N., Saim, A., & Hj Idrus, R. (2016). Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica. Malaysian Journal of Medical Science, 23(1), 4\u201314.","journal-title":"Malaysian Journal of Medical Science"},{"issue":"3","key":"1607_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ecam\/nel024","volume":"3","author":"KG Mohandas Rao","year":"2006","unstructured":"Mohandas Rao, K. G., Muddanna Rao, S., & Gurumadhva Rao, S. (2006). Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats. Evidance-Based Complementary & Alternative Medicine, 3(3), 349\u2013357. https:\/\/doi.org\/10.1093\/ecam\/nel024.","journal-title":"Evidance-Based Complementary & Alternative Medicine"},{"key":"1607_CR62","doi-asserted-by":"publisher","first-page":"204.","DOI":"10.1186\/1472-6882-13-204","volume":"13","author":"O Wanakhachornkrai","year":"2013","unstructured":"Wanakhachornkrai, O., Pongrakhananon, V., Chunhacha, P., Wanasuntronwong, A., Vattanajun, A., & Tantisira, B., et al. (2013). Neuritogenic effect of standardized extract of Centella asiatica ECa233 on human neuroblastoma cells. BMC Complementary & Alternative Medicine, 13, 204. https:\/\/doi.org\/10.1186\/1472-6882-13-204.","journal-title":"BMC Complementary & Alternative Medicine"},{"key":"1607_CR63","unstructured":"Norfaizatul Shalida Omar, Zakaria, Z. A. C., Mian, T. S., Ngah, W. Z. W., & Mazlan, M. (2011). Centella asiatica modulates neuron cell survival by altering caspase-9 pathway. Journal of Medicinal Plants Research, 5(11), 2201\u2013109."},{"key":"1607_CR64","doi-asserted-by":"crossref","unstructured":"Abdul Gofir, S. W., & Mohammad Hakimi (2021). Potential neurological applications of Centella asiatica: a brief review. Indonesian Journal of Pharmacology and Technology, 2, 136\u2013143.","DOI":"10.22146\/ijpther.1693"},{"key":"1607_CR65","doi-asserted-by":"publisher","unstructured":"Malar, D. S., Prasanth, M. I., Brimson, J. M., Sharika, R., Sivamaruthi, B. S., & Chaiyasut, C., et al. (2020). Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson\u2019s Disease: A Review. Molecules, 25(17). https:\/\/doi.org\/10.3390\/molecules25173926.","DOI":"10.3390\/molecules25173926"},{"key":"1607_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/161092","volume":"2015","author":"N Bitu Pinto","year":"2015","unstructured":"Bitu Pinto, N., da Silva Alexandre, B., Neves, K. R., Silva, A. H., Leal, L. K., & Viana, G. S. (2015). Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson\u2019s Disease. Evidance-Based Complementary & Alternative Medicine, 2015, 161092 https:\/\/doi.org\/10.1155\/2015\/161092.","journal-title":"Evidance-Based Complementary & Alternative Medicine"},{"issue":"10","key":"1607_CR67","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3945\/jn.117.255034","volume":"147","author":"Q Xu","year":"2017","unstructured":"Xu, Q., Langley, M., Kanthasamy, A. G., & Reddy, M. B. (2017). Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease. Journal of Nutrition, 147(10), 1926\u20131931. https:\/\/doi.org\/10.3945\/jn.117.255034.","journal-title":"Journal of Nutrition"},{"key":"1607_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuint.2017.04.019","volume":"108","author":"A Martins","year":"2017","unstructured":"Martins, A., Schimidt, H. L., Garcia, A., Colletta Altermann, C. D., Santos, F. W., & Carpes, F. P., et al. (2017). Supplementation with different teas from Camellia sinensis prevents memory deficits and hippocampus oxidative stress in ischemia-reperfusion. Neurochemistry International, 108, 287\u2013295. https:\/\/doi.org\/10.1016\/j.neuint.2017.04.019.","journal-title":"Neurochemistry International"},{"issue":"1","key":"1607_CR69","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.sjbs.2019.11.025","volume":"27","author":"S Rubab","year":"2020","unstructured":"Rubab, S., Rizwani, G. H., Bahadur, S., Shah, M., Alsamadany, H., & Alzahrani, Y., et al. (2020). Neuropharmacological potential of various morphological parts of Camellia sinensis L. Saudi Journal of Biological Science, 27(1), 567\u2013573. https:\/\/doi.org\/10.1016\/j.sjbs.2019.11.025.","journal-title":"Saudi Journal of Biological Science"},{"key":"1607_CR70","doi-asserted-by":"publisher","unstructured":"Xu, Y., Liu, S., Zhu, L., Dai, L., Qian, W., & Zhang, J., et al. (2021). Green tea protects against hippocampal neuronal apoptosis in diabetic encephalopathy by inhibiting JNK\/MLCK signaling. Molecular Medicine Reports, 24(2). https:\/\/doi.org\/10.3892\/mmr.2021.12214.","DOI":"10.3892\/mmr.2021.12214"},{"key":"1607_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4236\/jbbs.2015.56020","volume":"5","author":"DYZ Chen","year":"2015","unstructured":"Chen, D. Y. Z., Lyons, K. E., Pahwa, R., & Reddy, M. B. (2015). Green Tea Consumption Reduces Oxidative Stress in Parkinson\u2019s Disease Patients. Journal of Behavioral and Brain Science, 5, 194\u2013202. https:\/\/doi.org\/10.4236\/jbbs.2015.56020.","journal-title":"Journal of Behavioral and Brain Science"},{"issue":"4","key":"1607_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000265946","volume":"7","author":"L Reznichenko","year":"2010","unstructured":"Reznichenko, L., Kalfon, L., Amit, T., Youdim, M. B., & Mandel, S. A. (2010). Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. Neurodegenerative Disease, 7(4), 219\u2013231. https:\/\/doi.org\/10.1159\/000265946.","journal-title":"Neurodegenerative Disease"},{"issue":"1","key":"1607_CR73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1871527314666150202151440","volume":"14","author":"P Montes","year":"2015","unstructured":"Montes, P., Ruiz-Sanchez, E., Rojas, C., & Rojas, P. (2015). Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders. CNS Neurology Disorder Drug Targets, 14(1), 132\u2013149. https:\/\/doi.org\/10.2174\/1871527314666150202151440.","journal-title":"CNS Neurology Disorder Drug Targets"},{"issue":"3","key":"1607_CR74","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","volume":"16","author":"SK Singh","year":"2019","unstructured":"Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019). Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics, 16(3), 666\u2013674. https:\/\/doi.org\/10.1007\/s13311-019-00767-8.","journal-title":"Neurotherapeutics"},{"key":"1607_CR75","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.phytochem.2016.05.005","volume":"130","author":"S Beck","year":"2016","unstructured":"Beck, S., & Stengel, J. (2016). Mass spectrometric imaging of flavonoid glycosides and biflavonoids in Ginkgo biloba L. Phytochemistry, 130, 201\u2013206. https:\/\/doi.org\/10.1016\/j.phytochem.2016.05.005.","journal-title":"Phytochemistry"},{"issue":"17","key":"1607_CR76","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1055\/a-0947-5712","volume":"85","author":"I Martinez-Solis","year":"2019","unstructured":"Martinez-Solis, I., Acero, N., Bosch-Morell, F., Castillo, E., Gonzalez-Rosende, M. E., & Munoz-Mingarro, D., et al. (2019). Neuroprotective Potential of Ginkgo biloba in Retinal Diseases. Planta Medicine, 85(17), 1292\u20131303. https:\/\/doi.org\/10.1055\/a-0947-5712.","journal-title":"Planta Medicine"},{"issue":"12","key":"1607_CR77","doi-asserted-by":"publisher","first-page":"e0225761.","DOI":"10.1371\/journal.pone.0225761","volume":"14","author":"I Lejri","year":"2019","unstructured":"Lejri, I., Grimm, A., & Eckert, A. (2019). Ginkgo biloba extract increases neurite outgrowth and activates the Akt\/mTOR pathway. PLoS One, 14(12), e0225761. https:\/\/doi.org\/10.1371\/journal.pone.0225761.","journal-title":"PLoS One"},{"key":"1607_CR78","doi-asserted-by":"publisher","unstructured":"Ying, T., Mak, MSMW, & Yew, D.T. The Neuroprotective Effect of Ginkgo biloba Leaf Extract and its Possible Mechanism. Central Nervous System Agents in Medicinal Chemistry. 7(4), 230\u2013235. https:\/\/doi.org\/10.2174\/187152407783220850.","DOI":"10.2174\/187152407783220850"},{"issue":"4","key":"1607_CR79","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2174\/1570161117666190704092841","volume":"18","author":"W Yang","year":"2020","unstructured":"Yang, W., Ip, S. P., Liu, L., Xian, Y. F., & Lin, Z. X. (2020). Uncaria rhynchophylla and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions. Current Vascular Pharmacology, 18(4), 346\u2013357. https:\/\/doi.org\/10.2174\/1570161117666190704092841.","journal-title":"Current Vascular Pharmacology"},{"issue":"4","key":"1607_CR80","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1159\/000490837","volume":"47","author":"YL Lan","year":"2018","unstructured":"Lan, Y. L., Zhou, J. J., Liu, J., Huo, X. K., Wang, Y. L., & Liang, J. H., et al. (2018). Uncaria rhynchophylla Ameliorates Parkinson\u2019s Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics. Cell Physiology & Biochemistry, 47(4), 1453\u20131464. https:\/\/doi.org\/10.1159\/000490837.","journal-title":"Cell Physiology & Biochemistry"},{"key":"1607_CR81","doi-asserted-by":"publisher","first-page":"768.","DOI":"10.3389\/fphar.2018.00768","volume":"9","author":"S Hu","year":"2018","unstructured":"Hu, S., Mak, S., Zuo, X., Li, H., Wang, Y., & Han, Y. (2018). Neuroprotection Against MPP(+)-Induced Cytotoxicity Through the Activation of PI3-K\/Akt\/GSK3beta\/MEF2D Signaling Pathway by Rhynchophylline, the Major Tetracyclic Oxindole Alkaloid Isolated From Uncaria rhynchophylla. Frontiers in Pharmacology, 9, 768. https:\/\/doi.org\/10.3389\/fphar.2018.00768.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/636091","volume":"2012","author":"DD Xu","year":"2012","unstructured":"Xu, D. D., Hoeven, R., Rong, R., & Cho, W. C. (2012). Rhynchophylline Protects Cultured Rat Neurons against Methamphetamine Cytotoxicity. Evidance-Based Complementary & Alternative Medicine, 2012, 636091. https:\/\/doi.org\/10.1155\/2012\/636091.","journal-title":"Evidance-Based Complementary & Alternative Medicine"},{"key":"1607_CR83","doi-asserted-by":"publisher","unstructured":"Vilar DdeA, Vilar, M. S., de Lima e Moura, T. F., Raffin, F. N., de Oliveira, M. R., Franco, C. F., et al. (2014). Traditional uses, chemical constituents, and biological activities of Bixa orellana L.: a review. Scientific World Journal. 857292. https:\/\/doi.org\/10.1155\/2014\/857292.","DOI":"10.1155\/2014\/857292"},{"issue":"6","key":"1607_CR84","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s13197-017-2579-7","volume":"54","author":"D Raddatz-Mota","year":"2017","unstructured":"Raddatz-Mota, D., Perez-Flores, L. J., Carrari, F., Mendoza-Espinoza, J. A., de Leon-Sanchez, F. D., & Pinzon-Lopez, L. L., et al. (2017). Achiote (Bixa orellana L.): a natural source of pigment and vitamin E. Journal of Food Science & Technology, 54(6), 1729\u20131741. https:\/\/doi.org\/10.1007\/s13197-017-2579-7.","journal-title":"Journal of Food Science & Technology"},{"key":"1607_CR85","doi-asserted-by":"publisher","unstructured":"Syed Mansoor Ahamed, N. R., Shravan Narasimha, K. V., Veeresh, P. V., Manjunatha, E., & Sumana, T. (2024). Neuroprotective effect of bixin isolated from bixa orellana linn. On monosodium glutmate induced neurotoxicity in rats. Neuroquantology. 22(1). https:\/\/doi.org\/10.48047\/nq.2024.22.1.NQ24012.","DOI":"10.48047\/nq.2024.22.1.NQ24012"},{"key":"1607_CR86","unstructured":"Syeda Zareen Sabira, Armughan Aymen Mastan, K. Rama Rao, & Anupama Koneru (2022). Neuroprotective and antioxidant activity of bixa orellana against scopolamine-induced memory impairment in animal mode. Journal of Emerging Technologies and Innovative Research, 9(9), 1\u201349."},{"key":"1607_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112226","volume":"247","author":"P Petramfar","year":"2020","unstructured":"Petramfar, P., Hajari, F., Yousefi, G., Azadi, S., & Hamedi, A. (2020). Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson\u2019s disease, A randomized double blinded clinical trial. Journal of Ethnopharmacology, 247, 112226. https:\/\/doi.org\/10.1016\/j.jep.2019.112226.","journal-title":"Journal of Ethnopharmacology"},{"issue":"4","key":"1607_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3736\/jintegrmed2013035","volume":"11","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Ma, Y. Z., & Shen, X. M. (2013). Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson\u2019s disease: study protocol of a multicenter, open-label, randomized active-controlled trial. Journal of Integrated Medicine, 11(4), 285\u2013290. https:\/\/doi.org\/10.3736\/jintegrmed2013035.","journal-title":"Journal of Integrated Medicine"},{"key":"1607_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112432","volume":"156","author":"S Suroowan","year":"2021","unstructured":"Suroowan, S., Abdallah, H. H., & Mahomoodally, M. F. (2021). Herb-drug interactions and toxicity: Underscoring potential mechanisms and forecasting clinically relevant interactions induced by common phytoconstituents via data mining and computational approaches. Food & Chemical Toxicology, 156, 112432. https:\/\/doi.org\/10.1016\/j.fct.2021.112432.","journal-title":"Food & Chemical Toxicology"},{"issue":"4","key":"1607_CR90","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3233\/JPD-212647","volume":"11","author":"S Riggare","year":"2021","unstructured":"Riggare, S., Hagglund, M., Bredenoord, A. L., de Groot, M., & Bloem, B. R. (2021). Ethical Aspects of Personal Science for Persons with Parkinson\u2019s Disease: What Happens When Self-Tracking Goes from Selfcare to Publication? Journal of Parkinsons Disease, 11(4), 1927\u20131933. https:\/\/doi.org\/10.3233\/JPD-212647.","journal-title":"Journal of Parkinsons Disease"},{"key":"1607_CR91","doi-asserted-by":"publisher","first-page":"177.","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"M Ekor","year":"2014","unstructured":"Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https:\/\/doi.org\/10.3389\/fphar.2013.00177.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2022.104208","volume":"137","author":"Y-TL Bor-Yann Chen","year":"2022","unstructured":"Bor-Yann Chen, Y.-T. L., & Hsueh, C.-C. (2022). Synergic efficacy of bioenergy expression for compound herbal medicine of Parkinson\u2019s disease: The methods of replacement series and concentration addition. Journal of the Taiwan Institute of Chemical Engineers, 137, 104208. https:\/\/doi.org\/10.1016\/j.jtice.2022.104208.","journal-title":"Journal of the Taiwan Institute of Chemical Engineers"},{"key":"1607_CR93","doi-asserted-by":"publisher","unstructured":"Wu, T., Fang, X., Xu, J., Jiang, Y., Cao, F., & Zhao, L. (2020). Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson\u2019s Disease. Molecules. 25(17). https:\/\/doi.org\/10.3390\/molecules25173976.","DOI":"10.3390\/molecules25173976"},{"key":"1607_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3612587","volume":"2019","author":"TY Hwang","year":"2019","unstructured":"Hwang, T. Y., Song, M. A., Ahn, S., Oh, J. Y., Kim, D. H., & Liu, Q. F., et al. (2019). Effects of Combined Treatment with Acupuncture and Chunggan Formula in a Mouse Model of Parkinson\u2019s Disease. Evidence-Based Complementary & Alternative Medicine, 2019, 3612587. https:\/\/doi.org\/10.1155\/2019\/3612587.","journal-title":"Evidence-Based Complementary & Alternative Medicine"},{"issue":"1","key":"1607_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3233\/JPD-230168","volume":"14","author":"C Carroll","year":"2024","unstructured":"Carroll, C., Clarke, C. E., Grosset, D., Rather, A., Mohamed, B., & Parry, M., et al. (2024). Addressing Comorbidities in People with Parkinson\u2019s Disease: Considerations From An Expert Panel. Journal of Parkinsons Disease, 14(1), 53\u201363. https:\/\/doi.org\/10.3233\/JPD-230168.","journal-title":"Journal of Parkinsons Disease"},{"issue":"Suppl 3","key":"1607_CR96","doi-asserted-by":"publisher","first-page":"III\/24-9.","DOI":"10.1007\/s00415-002-1305-0","volume":"249","author":"WH Jost","year":"2002","unstructured":"Jost, W. H., & Bruck, C. (2002). Drug interactions in the treatment of Parkinson\u2019s disease. Journal of Neurology, 249(Suppl 3), III\/24-9. https:\/\/doi.org\/10.1007\/s00415-002-1305-0.","journal-title":"Journal of Neurology"},{"key":"1607_CR97","unstructured":"Hellicar, L. Parkinson\u2019s disease: Which medications should you avoid?: Medical News Today; 2022 [Available from: https:\/\/www.medicalnewstoday.com\/articles\/parkinson-disease-medications-to-avoid."},{"issue":"1","key":"1607_CR98","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00702-020-02276-x","volume":"128","author":"S Greten","year":"2021","unstructured":"Greten, S., Muller-Funogea, J. I., Wegner, F., Hoglinger, G. U., Simon, N., & Junius-Walker, U., et al. (2021). Drug safety profiles in geriatric patients with Parkinson\u2019s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis. Journal of Neural Transmission (Vienna), 128(1), 49\u201360. https:\/\/doi.org\/10.1007\/s00702-020-02276-x.","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"1607_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.976385","volume":"13","author":"MM Rahman","year":"2022","unstructured":"Rahman, M. M., Wang, X., Islam, M. R., Akash, S., Supti, F. A., & Mitu, M. I., et al. (2022). Multifunctional role of natural products for the treatment of Parkinson\u2019s disease: At a glance. Frontiers in Pharmacology, 13, 976385. https:\/\/doi.org\/10.3389\/fphar.2022.976385.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.936054","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Chen, Z., Li, A., Liu, R., Yang, H., & Xia, X. (2022). The Phytochemical Potential for Brain Disease Therapy and the Possible Nanodelivery Solutions for Brain Access. Frontiers in Oncology, 12, 936054. https:\/\/doi.org\/10.3389\/fonc.2022.936054.","journal-title":"Frontiers in Oncology"},{"key":"1607_CR101","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/IJN.S347187","volume":"17","author":"S Fakhri","year":"2022","unstructured":"Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022). Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases. International Journal of Nanomedicine, 17, 299\u2013331. https:\/\/doi.org\/10.2147\/IJN.S347187.","journal-title":"International Journal of Nanomedicine"},{"key":"1607_CR102","doi-asserted-by":"publisher","unstructured":"Uygur, E., Karatay, K. B., Dervis, E., Evren, V., Kilcar, Y., & Guldu, O. K., et al. (2024). Synthesis of Novel Plant-Derived Encapsulated Radiolabeled Compounds for the Diagnosis of Parkinson\u2019s Disease and the Evaluation of Biological Effects with In Vitro\/In Vivo Methods. Molecular Neurobiology, 2024. https:\/\/doi.org\/10.1007\/s12035-024-04103-w.","DOI":"10.1007\/s12035-024-04103-w"},{"key":"1607_CR103","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-3-319-28383-8_23","volume":"12","author":"T Sengupta","year":"2016","unstructured":"Sengupta, T., Vinayagam, J., Singh, R., Jaisankar, P., & Mohanakumar, K. P. (2016). Plant-Derived Natural Products for Parkinson\u2019s Disease Therapy. Advanced Neurobiology, 12, 415\u2013496. https:\/\/doi.org\/10.1007\/978-3-319-28383-8_23.","journal-title":"Advanced Neurobiology"},{"key":"1607_CR104","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.addr.2021.02.001","volume":"171","author":"Z Vinarov","year":"2021","unstructured":"Vinarov, Z., Abrahamsson, B., Artursson, P., Batchelor, H., Berben, P., & Bernkop-Schnurch, A., et al. (2021). Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Advanced Drug Delivery Review, 171, 289\u2013331. https:\/\/doi.org\/10.1016\/j.addr.2021.02.001.","journal-title":"Advanced Drug Delivery Review"},{"key":"1607_CR105","unstructured":"Verma, AST, P., Deshmukh, K., Jha, A.K., & Verma, S. (2010). Routes of Drug Administration. International Journal of Pharmaceutical Studies and Research, 1(1), 54\u201359."},{"key":"1607_CR106","doi-asserted-by":"publisher","unstructured":"Kyriakoudi, A., Spanidi, E., Mourtzinos, I., & Gardikis, K. (2021). Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications. Plants (Basel). 10(6). https:\/\/doi.org\/10.3390\/plants10061238.","DOI":"10.3390\/plants10061238"},{"key":"1607_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1256361","volume":"11","author":"A Alogla","year":"2023","unstructured":"Alogla, A. (2023). Enhancing antioxidant delivery through 3D printing: a pathway to advanced therapeutic strategies. Front Bioeng Biotechnol, 11, 1256361. https:\/\/doi.org\/10.3389\/fbioe.2023.1256361.","journal-title":"Front Bioeng Biotechnol"},{"key":"1607_CR108","doi-asserted-by":"publisher","unstructured":"Gretarsdottir, H. M., Widman, E., Johansson, A., & Nyholm, D. (2021). Personalized Medicine Approach in Treating Parkinson\u2019s Disease, Using Oral Administration of Levodopa\/Carbidopa Microtablets in Clinical Practice. Journal of Personalised Medicine, 11(8). https:\/\/doi.org\/10.3390\/jpm11080720.","DOI":"10.3390\/jpm11080720"},{"key":"1607_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1330098","volume":"14","author":"GM Hasan","year":"2023","unstructured":"Hasan, G. M., Anwar, S., Shamsi, A., Sohal, S. S., & Hassan, M. I. (2023). The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications. Frontiers in Pharmacology, 14, 1330098. https:\/\/doi.org\/10.3389\/fphar.2023.1330098.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106076","volume":"177","author":"CL Wainwright","year":"2022","unstructured":"Wainwright, C. L., Teixeira, M. M., Adelson, D. L., Buenz, E. J., David, B., & Glaser, K. B., et al. (2022). Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review. Pharmacology Research, 177, 106076 https:\/\/doi.org\/10.1016\/j.phrs.2022.106076.","journal-title":"Pharmacology Research"},{"key":"1607_CR111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-319-41334-1_14","volume":"928","author":"PT White","year":"2016","unstructured":"White, P. T., Subramanian, C., Motiwala, H. F., & Cohen, M. S. (2016). Natural Withanolides in the Treatment of Chronic Diseases. Advances in Experimental Medicine and Biology, 928, 329\u2013373. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_14.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"5","key":"1607_CR112","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-013-1005-4","volume":"38","author":"J Prakash","year":"2013","unstructured":"Prakash, J., Yadav, S. K., Chouhan, S., & Singh, S. P. (2013). Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochemical Research, 38(5), 972\u2013980. https:\/\/doi.org\/10.1007\/s11064-013-1005-4.","journal-title":"Neurochemical Research"},{"issue":"6","key":"1607_CR113","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neuro.2009.08.012","volume":"30","author":"R Hosamani","year":"2009","unstructured":"Hosamani, R., & Muralidhara (2009). Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster. Neurotoxicology, 30(6), 977\u2013985. https:\/\/doi.org\/10.1016\/j.neuro.2009.08.012.","journal-title":"Neurotoxicology"},{"issue":"3","key":"1607_CR114","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10571-011-9776-0","volume":"32","author":"GK Shinomol","year":"2012","unstructured":"Shinomol, G. K., Mythri, R. B., Srinivas Bharath, M. M., & Muralidhara (2012). Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain. Cell Molecular Neurobiology, 32(3), 455\u2013465. https:\/\/doi.org\/10.1007\/s10571-011-9776-0.","journal-title":"Cell Molecular Neurobiology"},{"issue":"12","key":"1607_CR115","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","volume":"62","author":"S Guo","year":"2007","unstructured":"Guo, S., Yan, J., Yang, T., Yang, X., Bezard, E., & Zhao, B. (2007). Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson\u2019s disease through inhibition of ROS-NO pathway. Biological Psychiatry, 62(12), 1353\u20131362. https:\/\/doi.org\/10.1016\/j.biopsych.2007.04.020.","journal-title":"Biological Psychiatry"},{"issue":"5","key":"1607_CR116","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25032","volume":"14","author":"A Patel","year":"2022","unstructured":"Patel, A., Olang, C. A., Lewis, G., Mandalaneni, K., Anand, N., & Gorantla, V. R. (2022). An Overview of Parkinson\u2019s Disease: Curcumin as a Possible Alternative Treatment. Cureus, 14(5), e25032. https:\/\/doi.org\/10.7759\/cureus.25032.","journal-title":"Cureus"},{"issue":"5","key":"1607_CR117","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1389450120666191112155654","volume":"21","author":"OR Tamtaji","year":"2020","unstructured":"Tamtaji, O. R., Hadinezhad, T., Fallah, M., Shahmirzadi, A. R., Taghizadeh, M., & Behnam, M., et al. (2020). The Therapeutic Potential of Quercetin in Parkinson\u2019s Disease: Insights into its Molecular and Cellular Regulation. Current Drug Targets, 21(5), 509\u2013518. https:\/\/doi.org\/10.2174\/1389450120666191112155654.","journal-title":"Current Drug Targets"},{"key":"1607_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845591","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng, Z., Kang, C., Che, S., Su, J., Sun, Q., & Ge, T., et al. (2022). Berberine: A Promising Treatment for Neurodegenerative Diseases. Frontiers in Pharmacology, 13, 845591. https:\/\/doi.org\/10.3389\/fphar.2022.845591.","journal-title":"Frontiers in Pharmacology"},{"key":"1607_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.687935","volume":"12","author":"JH Wong","year":"2021","unstructured":"Wong, J. H., Barron, A. M., & Abdullah, J. M. (2021). Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease. Frontiers in Pharmacology, 12, 687935. https:\/\/doi.org\/10.3389\/fphar.2021.687935.","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"1607_CR120","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/1871527322666230406082625","volume":"23","author":"K Gaur","year":"2024","unstructured":"Gaur, K., & Siddique, Y. H. (2024). Effect of Apigenin on Neurodegenerative Diseases. CNS & Neurological Disorders Drug Targets, 23(4), 468\u2013475. https:\/\/doi.org\/10.2174\/1871527322666230406082625.","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"1607_CR121","doi-asserted-by":"publisher","unstructured":"Ahmad, R., Khan, A., Lee, H. J., Ur Rehman, I., Khan, I., & Alam, S. I., et al. (2020). Lupeol, a Plant-Derived Triterpenoid, Protects Mice Brains against Abeta-Induced Oxidative Stress and Neurodegeneration. Biomedicines. 8(10). https:\/\/doi.org\/10.3390\/biomedicines8100380.","DOI":"10.3390\/biomedicines8100380"},{"issue":"6","key":"1607_CR122","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3892\/etm.2021.9984","volume":"21","author":"YB He","year":"2021","unstructured":"He, Y. B., Liu, Y. L., Yang, Z. D., Lu, J. H., Song, Y., & Guan, Y. M., et al. (2021). Effect of ginsenoside-Rg1 on experimental Parkinson\u2019s disease: A systematic review and meta-analysis of animal studies. Experimental and Therapeutic Medicine, 21(6), 552 https:\/\/doi.org\/10.3892\/etm.2021.9984.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"1607_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1036-x","volume":"14","author":"Z Fan","year":"2017","unstructured":"Fan, Z., Liang, Z., Yang, H., Pan, Y., Zheng, Y., & Wang, X. (2017). Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia. Journal of Neuroinflammation, 14(1), 256. https:\/\/doi.org\/10.1186\/s12974-017-1036-x.","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"1607_CR124","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3892\/ijmm.2015.2356","volume":"36","author":"W Yang","year":"2015","unstructured":"Yang, W., Chen, Y. H., Liu, H., & Qu, H. D. (2015). Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease mouse model. International Journal of Molecular Medicine, 36(5), 1369\u20131376. https:\/\/doi.org\/10.3892\/ijmm.2015.2356.","journal-title":"International Journal of Molecular Medicine"},{"issue":"10","key":"1607_CR125","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/gps.949","volume":"18","author":"D Aarsland","year":"2003","unstructured":"Aarsland, D., Hutchinson, M., & Larsen, J. P. (2003). Cognitive, psychiatric and motor response to galantamine in Parkinson\u2019s disease with dementia. International Journal of Geriatric Psychiatry, 18(10), 937\u2013941. https:\/\/doi.org\/10.1002\/gps.949.","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"1607_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175970","volume":"956","author":"X Guo","year":"2023","unstructured":"Guo, X., Wu, Y., Wang, Q., Zhang, J., Sheng, X., & Zheng, L., et al. (2023). Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson\u2019s disease. European Journal of Pharmacology, 956, 175970. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175970.","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"1607_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88910-4","volume":"11","author":"A Carvajal-Oliveros","year":"2021","unstructured":"Carvajal-Oliveros, A., Dominguez-Baleon, C., Zarate, R. V., Campusano, J. M., Narvaez-Padilla, V., & Reynaud, E. (2021). Nicotine suppresses Parkinson\u2019s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels. Science Reports, 11(1), 9579. https:\/\/doi.org\/10.1038\/s41598-021-88910-4.","journal-title":"Science Reports"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01607-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01607-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T03:28:26Z","timestamp":1747625306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01607-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":127,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01607-z","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"29 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}